Administration of the CXCR4 antagonist AMD 3100 reversed this observation and led to a release of HSC progenitor cells from the bone marrow and fast generalized leukocytosis, demonstrating the importance of CXCL12 as a retention signal for HSC in the bone [27–29]. Here, CXCL12 is linked to Increased total leukocyte count.